U-28,774 (ketozolam) : an early evaluation of a new antianxiety agent
Gallant, D.M.; Guerrero-Figueroa, R.; Swanson, W.C.
Current Therapeutic Research 15(3): 123-126
1973
ISSN/ISBN: 0011-393X PMID: 4196228 Document Number: 59820
Document emailed within 1 workday
Related Documents
Short, C.E.; Miller, R.L. 1978: Comparative evaluation of the anticholinergic agent glycopyrrolate as a preanesthetic agent Veterinary Medicine-Small Animal Clinician 73(10): 1269-1273Gorman, J.M. 2003: New molecular targets for antianxiety interventions Journal of Clinical Psychiatry 64(Suppl 3): 28-35
Lofft, J.G.; Demars, J.P. 1974: A chemotherapeutic alternative to the antianxiety agents for the extended treatment of psychoneurosis Diseases of the Nervous System 35(9): 409-415
Roychoudhury, M.; Kulkarni, S.K. 1997: Antianxiety profile of ondansetron, a selective 5-HT3 antagonist, in a novel animal model Methods and Findings in Experimental and Clinical Pharmacology 19(2): 107-111
Solomon, K.; Hart, R. 1978: Pitfalls and prospects in clinical research on antianxiety drugs: benzodiazepines and placebo--a research review Journal of Clinical Psychiatry 39(11): 823-831
Olsuf'ev, N.G.; Ananova, E.V.; Meshcheriakova, I.S.; Savel'eva, R.A. 1975: Detection of the causative agent of tularemia in the organs of animals in the early stages of development of the infection Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 10: 13-17
Ryba, D.; Halpern, S. 1971: Evaluation of a new psychopharmacological agent in cardiology Minerva Cardioangiologica 19(3): 172-177
Stejskal, D.; Růzicka, V.; Bartek, J. 1998: Serum leptin, early atherosclerosis and hypolipidemia (a new, previously undescribed effect of pravastatin, a hypolipemic agent) Vnitrni Lekarstvi 44(10): 582-587
Taetle, R.; Howell, S.B. 1983: Preclinical re-evaluation of benzaldehyde as a chemotherapeutic agent Cancer Treatment Reports 67(6): 561-566
Stowater, J.L.; Kneller, S.K. 1979: Clinical evaluation of metrizamide as a myelographic agent in the dog Journal of the American Veterinary Medical Association 175(2): 191-195
Beritić, T. 1971: Clinical evaluation of a new antihistaminic agent--Tavergyl Lijecnicki Vjesnik 83(9): 1065-1070
Pasricha, A.; Bhalla, P.; Sharma, K.B. 1979: Evaluation of Lactic Acid as an Antibacterial Agent Indian Journal of Dermatology Venereology and Leprology 45(3): 159-161
Tanga, M.R.; Antani, J.A.; Kabade, S.S. 1975: Clinical evaluation of metronidazole as an anti-inflammatory agent International Surgery 60(2): 75-76
Lasich, A.J. 1974: Evaluation of lorazepam as an anxiolytic agent in psychiatric practice South African Medical Journal 48(16): 681-683
Doongaji, D.R.; Sheth, A.S.; Paul, T.; Parikh, R.M.; Vahora, S.A.; Apte, J.S.; Desai, N.K.; Upadhaya, A.K.; Satoskar, R.S. 1983: Clinical evaluation of centbutindole as an anti-psychotic agent Indian Journal of Medical Research 78: 126-133
Kosman, M.E. 1975: Evaluation of clonidine hydrochloride (Catapres). a new antihypertensive agent JAMA 233(2): 174-176
Kramer, R.; Rosendorff, C.; Bloom, D. 1974: Clinical evaluation of indoramin as the sole agent for the treatment of hypertension South African Medical Journal 48(37): 1569-1572
Tsuboi, T.; Hatano, N.; Nakatsuji, K.; Fujitani, B.; Yoshida, K.; Shimizu, M.; Kawasaki, A.; Sakata, M.; Tsuboshima, M. 1980: Pharmacological evaluation of OP 1206, a prostaglandin E1 derivative, as an antianginal agent Archives Internationales de Pharmacodynamie et de Therapie 247(1): 89-102
Bazin, J.E.; Giannelloni, C.; Dauphin, C.; Curt, I.; Montétagaud, M.; Motreff, P.; Pierre-Justin, E.; Lusson, J.R. 1997: Evaluation of sevoflurane, new anesthetic agent during pediatric cardiac catheterization Archives des Maladies du Coeur et des Vaisseaux 90(5): 657-660
Nishimura, H.; Ikehara, O.; Naito, T.; Higuchi, C.; Sanaka, T. 2009: Evaluation of taurine as an osmotic agent for peritoneal dialysis solution Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 29(2): 204-216